Overview

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
Study to learn if the alternate formulation is effective in agitated schizophrenic patients
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Treatments:
Aripiprazole